Sunshine Act Meeting, 60416 [2015-25451]
Download as PDF
<![CDATA[
60416
Federal Register / Vol. 80, No. 193 / Tuesday, October 6, 2015 / Notices
plant pest provisions of the PPA or to
regulatory requirements when APHIS
determines that it is unlikely to pose a
plant pest risk.
The EPA under the Federal
Insecticide, Fungicide, and Rodenticide
Act (FIFRA) and the FD&C Act regulates
the sale and distribution of all
pesticides, including those produced
through genetic engineering. This
includes microorganisms, biochemicals
isolated from organisms, and plantincorporated protectants (PIPs), a type
of pesticide intended to be produced
and used in living plants. Under the
Toxic Substances Control Act (TSCA),
EPA has oversight responsibilities for a
wide range of commercial, industrial,
and consumer applications of microbial
biotechnology. New chemicals
produced through those microbial
biotechnology applications are subject
to premanufacturing review under
TSCA.
tkelley on DSK3SPTVN1PROD with NOTICES
Questions
Keeping in mind the principles of the
regulation of the products of
biotechnology as articulated in the CF
and the 1992 update to the CF, as well
as the objectives of the July 2, 2015 EOP
memorandum, respondents are welcome
to address one or more of the following
questions in regards to the proposed
update to the CF and the development
of the long-term strategy. Respondents
are asked to indicate to which question
responses are targeted.
1. What additional clarification could
be provided regarding which
biotechnology product areas are within
the statutory authority and
responsibility of each agency?
2. What additional clarification could
be provided regarding the roles that
each agency plays for different
biotechnology product areas,
particularly for those product areas that
fall within the responsibility of multiple
agencies, and how those roles relate to
each other in the course of a regulatory
assessment?
3. How can Federal agencies improve
their communication to consumers,
industry, and other stakeholders
regarding the authorities, practices, and
bases for decision-making used to
ensure the safety of the products of
biotechnology?
4. Are there relevant data and
information, including case studies, that
can inform the update to the CF or the
development of the long-term strategy
regarding how to improve the
transparency, coordination,
predictability, and efficiency of the
regulatory system for the products of
biotechnology?
VerDate Sep<11>2014
18:31 Oct 05, 2015
Jkt 238001
5. Are there specific issues that
should be addressed in the update of the
CF or in the long-term strategy in order
to increase the transparency,
coordination, predictability, and
efficiency of the regulatory system for
the products of biotechnology?
References
These references are available
electronically at https://
www.regulations.gov. We have verified
the Web site addresses, but we are not
responsible for any subsequent changes
to Web sites after this document
publishes in the Federal Register.
1. Executive Office of the President. Office of
Science and Technology Policy, Office of
Management and Budget, United States
Trade Representative, and Council on
Environmental Quality. Modernizing the
Regulatory System for Biotechnology
Products, July 2, 2015. Available online
at: https://www.whitehouse.gov/sites/
default/files/microsites/ostp/
modernizing_the_reg_system_for_
biotech_products_memo_final.pdf.
2. Executive Office of the President. Office of
Science and Technology Policy.
Coordinated Framework for Regulation
of Biotechnology. 51 FR 23302, June 26,
1986. Available online at: https://
www.aphis.usda.gov/brs/fedregister/
coordinated_framework.pdf
3. Executive Office of the President. Office of
Science and Technology Policy. Exercise
of Federal Oversight Within Scope of
Statutory Authority: Planned
Introductions of Biotechnology Products
Into the Environment. 57 FR 6753,
February 27, 1992. Available online at:
https://www.whitehouse.gov/sites/
default/files/microsites/ostp/57_fed_reg_
6753__1992.pdf
Ted Wackler,
Deputy Chief of Staff and Assistant Director.
[FR Doc. 2015–25325 Filed 10–5–15; 8:45 am]
BILLING CODE 3270–F5–P
SECURITIES AND EXCHANGE
COMMISSION
Sunshine Act Meeting
Notice is hereby given, pursuant to
the provisions of the Government in the
Sunshine Act, Public Law 94–409, that
the Securities and Exchange
Commission will hold a Closed Meeting
on Thursday, October 8, 2015 at 2:00
p.m.
Commissioners, Counsel to the
Commissioners, the Secretary to the
Commission, and recording secretaries
will attend the Closed Meeting. Certain
staff members who have an interest in
the matters also may be present.
The General Counsel of the
Commission, or her designee, has
certified that, in her opinion, one or
PO 00000
Frm 00068
Fmt 4703
Sfmt 4703
more of the exemptions set forth in 5
U.S.C. 552b(c)(3), (5), (7), 9(B) and (10)
and 17 CFR 200.402(a)(3), (5), (7), 9(ii)
and (10), permit consideration of the
scheduled matter at the Closed Meeting.
Commissioner Stein, as duty officer,
voted to consider the items listed for the
Closed Meeting in closed session.
The subject matter of the Closed
Meeting will be:
Institution and settlement of
injunctive actions;
Institution and settlement of
administrative proceedings;
Adjudicatory matters; and
Other matters relating to enforcement
proceedings.
At times, changes in Commission
priorities require alterations in the
scheduling of meeting items.
For further information and to
ascertain what, if any, matters have been
added, deleted or postponed, please
contact the Office of the Secretary at
(202) 551–5400.
Dated: October 1, 2015.
Brent J. Fields,
Secretary.
[FR Doc. 2015–25451 Filed 10–2–15; 11:15 am]
BILLING CODE 8011–01–P
SECURITIES AND EXCHANGE
COMMISSION
[Release No. 34–76059; File No. SR–FINRA–
2015–033]
Self-Regulatory Organizations;
Financial Industry Regulatory
Authority, Inc.; Notice of Filing of a
Proposed Rule Change To Amend
FINRA Rule 0150 to Apply FINRA Rule
2121 and its Supplementary Material
.01 and .02 to Transactions in
Exempted Securities That Are
Government Securities
September 30, 2015.
Pursuant to Section 19(b)(1) of the
Securities Exchange Act of 1934
(‘‘Act’’) 1 and Rule 19b–4 thereunder,2
notice is hereby given that on
September 17, 2015, Financial Industry
Regulatory Authority, Inc. (‘‘FINRA’’)
filed with the Securities and Exchange
Commission (‘‘SEC’’ or ‘‘Commission’’)
the proposed rule change as described
in Items I, II, and III below, which Items
have been substantially prepared by
FINRA. The Commission is publishing
this notice to solicit comments on the
proposed rule change from interested
persons.
1 15
2 17
E:\FR\FM\06OCN1.SGM
U.S.C. 78s(b)(1).
CFR 240.19b–4.
06OCN1
]]>Agencies
[Federal Register Volume 80, Number 193 (Tuesday, October 6, 2015)]
[Notices]
[Page 60416]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-25451]
=======================================================================
-----------------------------------------------------------------------
SECURITIES AND EXCHANGE COMMISSION
Sunshine Act Meeting
Notice is hereby given, pursuant to the provisions of the
Government in the Sunshine Act, Public Law 94-409, that the Securities
and Exchange Commission will hold a Closed Meeting on Thursday, October
8, 2015 at 2:00 p.m.
Commissioners, Counsel to the Commissioners, the Secretary to the
Commission, and recording secretaries will attend the Closed Meeting.
Certain staff members who have an interest in the matters also may be
present.
The General Counsel of the Commission, or her designee, has
certified that, in her opinion, one or more of the exemptions set forth
in 5 U.S.C. 552b(c)(3), (5), (7), 9(B) and (10) and 17 CFR
200.402(a)(3), (5), (7), 9(ii) and (10), permit consideration of the
scheduled matter at the Closed Meeting.
Commissioner Stein, as duty officer, voted to consider the items
listed for the Closed Meeting in closed session.
The subject matter of the Closed Meeting will be:
Institution and settlement of injunctive actions;
Institution and settlement of administrative proceedings;
Adjudicatory matters; and
Other matters relating to enforcement proceedings.
At times, changes in Commission priorities require alterations in
the scheduling of meeting items.
For further information and to ascertain what, if any, matters have
been added, deleted or postponed, please contact the Office of the
Secretary at (202) 551-5400.
Dated: October 1, 2015.
Brent J. Fields,
Secretary.
[FR Doc. 2015-25451 Filed 10-2-15; 11:15 am]
BILLING CODE 8011-01-P
